baculoviru
wide
use
product
recombin
protein
insect
cell
sinc
find
baculoviru
effici
transduc
mammalian
cell
applic
baculoviru
greatli
expand
prospect
drawback
baculovirusmedi
gene
express
either
insect
mammalian
cell
review
recent
progress
expand
applic
studi
gene
regul
viral
vector
prepar
vivo
ex
vivo
gene
therapi
studi
gener
vaccin
vector
etc
discuss
effort
direct
toward
overcom
exist
bottleneck
particularli
emphas
baculovirus
make
famili
virus
group
nuclear
polyhedrosi
virus
npv
granulosi
virus
differ
type
baculovirus
discov
host
rang
restrict
invertebr
mostli
insect
eg
moth
butterfli
thu
sever
baculovirus
eg
helicoverpa
zea
orgya
pseudotsugata
lymantria
dispar
regist
use
biolog
pesticid
us
environment
protect
agenc
among
numer
baculovirus
autographa
californica
multipl
npv
acmnpv
well
studi
extens
use
acmnpv
circular
doublestrand
dna
genom
approxim
kb
condens
protaminelik
protein
core
pack
nucleocapsid
nucleocapsid
synthes
nucleu
infect
cell
typic
nm
diamet
nm
length
membraneenvelop
nucleocapsid
refer
viru
particl
virion
natur
acmnpv
occlud
polyhedron
size
mainli
consist
polyhedrin
protein
ingest
insect
polyhedrin
matrix
dissolv
alkalin
midgut
thu
releas
embed
virion
subsequ
infect
epitheli
cell
intestin
earli
infect
cycl
dna
genom
replic
transcrib
nucleu
nucleocapsid
assembl
bud
nucleocapsid
plasma
membran
result
releas
bud
viru
respons
system
transmiss
within
infect
insect
late
infect
cycl
progeni
nucleocapsid
becom
membranebound
within
nucleu
embed
polyhedra
cell
death
lysi
polyhedra
releas
wild
spread
infect
bud
viru
highli
infecti
cultur
insect
cell
primari
form
use
laboratori
express
vector
baculoviru
wide
use
product
numer
recombin
protein
insect
cell
follow
advantag
proper
posttransl
modif
insect
cell
higher
eukaryot
ii
high
capac
multipl
gene
larg
insert
huge
flexibl
viral
genom
kb
iii
biosafeti
baculoviru
natur
infect
human
iv
high
yield
driven
strong
promot
polyhedrin
among
natur
host
cell
deriv
ovarian
tissu
spodoptera
frugiperda
highfiv
invitrogen
carlsbad
ca
usa
deriv
trichoplusia
ni
suitabl
express
secret
protein
popular
addit
cultur
cell
line
insect
larva
also
excel
host
protein
product
exampl
ni
insect
larva
readili
infect
recombin
acmnpv
silkworm
readili
infect
recombin
bombyx
mori
npv
system
employ
product
numer
recombin
protein
product
synthes
insect
larva
almost
ident
produc
insect
cell
mammalian
cell
yield
gener
high
eg
mg
luciferas
per
larva
therefor
baculoviru
infect
live
insect
may
repres
inexpens
rapid
approach
protein
product
consist
infect
qualiti
control
difficult
achiev
larg
clone
capac
render
baculoviru
ideal
tool
synthesi
viruslik
particl
vlp
gener
requir
simultan
express
multipl
viral
structur
protein
selfassembl
vlp
empti
particl
compos
viral
structur
protein
devoid
viral
nucleic
acid
thu
noninfecti
vlp
gener
induc
broad
strong
immun
respons
thank
preserv
mani
essenti
epitop
therefor
vlp
gain
increas
attent
potenti
vaccin
candid
diagnost
reagent
extend
applic
vlp
gene
deliveri
vehicl
also
report
date
numer
vlp
differ
virus
includ
hiv
herp
simplex
viru
human
papillomaviru
polyomaviru
parvoviru
infecti
bursal
diseas
viru
hepat
c
viru
hcv
enteroviru
express
use
baculovirusinsect
cell
express
system
recent
synthesi
sever
acut
respiratori
syndrom
coronaviru
sarscov
vlp
use
baculovirusinsect
cell
system
also
report
assembl
vlp
use
baculoviru
enabl
investig
viru
assembl
process
well
minim
requir
viral
capsid
assembl
exampl
mortola
roy
demonstr
coexpress
sarscov
envelop
membran
protein
requir
suffici
assembl
spikeless
vlp
yet
addit
coexpress
spike
protein
result
incorpor
protein
result
vlp
possess
distinct
spike
project
make
morpholog
indistinguish
authent
viru
coinfect
differ
recombin
baculovirus
one
manipul
composit
particl
obtain
higher
specif
immunogen
biolog
function
incorpor
enzym
affin
tag
downstream
purif
regard
conner
et
al
success
demonstr
chimer
vlp
form
structur
protein
virus
isol
differ
anim
bovin
simian
includ
viral
protein
differ
strain
refer
phenotyp
mix
one
broaden
spectrum
chimer
particl
vaccin
drawback
associ
baculoviru
insect
cell
express
system
first
baculoviru
infect
ultim
result
cell
death
lysi
day
express
driven
polyhedrin
promot
usual
reach
maximum
near
death
infect
cell
protein
process
like
suboptim
time
compromis
posttransl
machineri
secretori
pathway
may
serious
affect
process
protein
destin
plasma
membran
secret
effort
direct
toward
allevi
problem
use
earli
baculoviru
promot
eg
either
transient
stabli
transform
cell
express
driven
earli
promot
continu
stabl
confer
effici
process
glycoprotein
eg
tissu
plasminogen
activ
express
level
lower
obtain
lytic
baculoviru
system
system
feasibl
approach
express
insect
cell
product
rel
poorli
process
lytic
insect
cell
may
use
function
studi
recombin
receptor
protein
circumv
protein
degrad
problem
associ
cell
lysi
novel
nonlyt
baculoviru
recent
develop
random
mutagenesi
viral
genom
subsequ
select
postinfect
nonlyt
baculoviru
show
cell
lysi
contrast
cell
lysi
lytic
baculoviru
system
thu
conveni
altern
product
protein
vulner
degrad
use
lytic
baculovirus
second
disadvantag
glycosyl
insect
cell
differ
mani
aspect
mammalian
cell
exampl
truncat
oligosaccharid
contain
even
mannos
residu
sometim
fucos
found
protein
express
insect
cell
besid
appear
signific
sialyl
nglycan
insect
cell
glycoprotein
lack
sialic
acid
extrem
short
halfliv
vivo
therefor
truncat
nglycan
glycoprotein
produc
insect
cell
constitut
barrier
use
therapeut
one
exampl
engin
nglycosyl
pathway
construct
transform
cell
constitut
express
bovin
control
baculoviru
infect
cell
line
result
product
termin
galactosyl
recombin
protein
attempt
strategi
mammalian
h
uman
nglycosyl
capac
insect
cell
review
previous
anoth
limit
baculovirusinsect
cell
system
ineffici
properli
process
protein
initi
synthes
larg
inact
precursor
protein
peptid
hormon
matrix
metalloproteas
fusogen
viral
envelop
glycoprotein
famili
mammalian
proprotein
convertas
character
involv
cleavag
shown
coexpress
prohormon
convertas
furin
transform
growth
factor
tgf
result
increas
product
matur
tgf
baculoviru
origin
regard
infect
sole
insect
invertebr
volkman
goldsmith
found
baculoviru
intern
nontarget
vertebr
cell
eg
human
lung
carcinoma
cell
line
carbonel
et
al
confirm
entri
baculoviru
mammalian
cell
low
level
report
gene
express
control
polyhedrin
rou
sarcoma
viru
rsv
promot
mammalian
cell
howev
viru
replic
detect
either
studi
discoveri
wide
note
year
later
two
pioneer
group
report
recombin
baculovirus
harbor
cytomegaloviru
cmv
promoterluciferas
gene
cassett
rsv
long
termin
repeat
ltr
galactosidas
gene
cassett
effici
transduc
mammalian
cell
data
indic
strong
prefer
baculoviru
enter
hepatocyt
differ
origin
suggest
block
express
less
suscept
cell
appear
result
abil
intern
target
cell
rather
event
subsequ
viral
entri
high
low
express
cell
line
intern
similar
amount
viru
one
factor
account
low
appar
transduct
effici
cell
type
promot
strength
shoji
et
al
show
cell
transduc
baculoviru
express
control
cmv
promot
effici
transduc
baculoviru
express
report
protein
transcript
control
stronger
cag
promot
composit
promot
consist
cmv
immedi
earli
enhanc
chicken
promot
rabbit
polyadenyl
signal
thu
interest
examin
differ
promot
viral
cellular
origin
baculoviru
context
mammalian
cell
follow
find
subsequ
studi
rapidli
expand
list
permiss
cell
includ
cell
line
origin
human
eg
hela
keratinocyt
bone
marrow
fibroblast
rodent
eg
cho
bhk
porcin
eg
cpk
bovin
eg
bt
even
fish
sourc
eg
epc
besid
baculoviru
capabl
transduc
nondivid
cell
transduct
primari
cell
human
neural
cell
pancreat
islet
cell
rat
articular
chondrocyt
also
observ
addit
wagl
jesuthasan
recent
show
baculoviru
success
transduc
embryo
zebrafish
inject
baculoviru
express
specif
tissu
normal
express
posterior
region
develop
somit
baculovirusmedi
misexpress
caus
abnorm
somit
boundari
format
despit
rapidli
grow
list
suscept
cell
howev
baculoviru
transduct
cell
line
hematopoiet
origin
lclcm
raji
ineffici
transduct
effici
vari
consider
depend
cell
type
bhk
cell
lower
cell
one
possibl
account
high
transduct
effici
certain
cell
line
activ
mammalian
promot
eg
cmv
promot
heat
shock
promot
dna
sequenc
upstream
polyhedrin
pu
homolog
region
hr
acmnpv
sequenc
enhanc
transcript
polyhedrin
drosophila
heat
shock
protein
promot
sf
cell
function
origin
replic
ori
support
ori
activ
mammalian
cell
pu
hr
togeth
function
synergist
result
much
promot
activ
also
function
mammalian
cell
enhanc
present
tran
insert
addit
copi
region
acmnpv
genom
thu
repres
attract
approach
promot
overexpress
foreign
protein
mammalian
cell
demonstr
insect
cell
addit
also
help
maintain
genet
stabil
bacmidderiv
baculovirus
spontan
delet
heterolog
gene
foreign
bacteri
artifici
chromosom
sequenc
readili
occur
transduct
effici
markedli
enhanc
addit
sodium
butyr
trichostatin
valproic
acid
compound
histon
deacetylas
inhibitor
induc
hyperacetyl
chromatin
enhanc
transcript
thu
highlight
import
chromatin
state
baculoviru
genom
transduc
cell
transgen
express
howev
cytotox
often
associ
use
drug
anoth
approach
enhanc
transduct
effici
alter
transduct
protocol
transduct
typic
viru
concentr
ultracentrifug
resuspend
phosphatebuff
salin
pb
cell
incub
viru
h
use
growth
medium
eg
dmem
surround
solut
recent
found
incub
unconcentr
viru
ie
viru
supernat
lower
temperatur
eg
h
use
pb
surround
solut
result
gene
transfer
hela
chondrocyt
effici
compar
superior
use
tradit
protocol
part
prolong
viru
uptak
provid
suffici
amount
viru
present
one
key
determin
account
high
transduct
effici
pb
superior
dmem
tnmfh
medium
baculoviru
product
surround
solut
term
enhanc
transduct
effici
transgen
express
although
exact
mechan
await
elucid
protocol
also
confer
gene
deliveri
human
mesenchym
stem
cell
msc
isol
umbil
cord
blood
umsc
bone
marrow
bmsc
effici
approxim
respect
figur
protocol
elimin
need
viru
ultracentrifug
thu
repres
simpler
approach
also
consider
reduc
possibl
viru
inactiv
ultracentrifug
baculoviru
transduct
gener
consid
nontox
mammalian
cell
hinder
cell
growth
even
high
multipl
infect
recent
studi
confirm
notion
transduct
wildtyp
baculoviru
caus
observ
advers
effect
chondrocyt
msc
growth
curv
howev
note
slower
cell
prolifer
express
enhanc
green
fluoresc
protein
egfp
transcript
control
cmv
promot
slightli
retard
cell
growth
attribut
egfp
overexpress
egfp
overexpress
could
toxic
might
even
induc
apoptosi
cell
ii
transcript
activ
cmv
promot
could
repress
viral
cellular
gene
express
fortun
cell
growth
rate
may
restor
sever
passag
egfp
express
attenu
mechan
baculoviru
entri
mammalian
cell
baculoviru
enter
insect
cell
via
endocytosi
follow
low
phinduc
fusion
viral
envelop
protein
endosom
membran
thu
allow
viral
entri
cytoplasm
nucleu
likewis
baculoviru
gener
consid
follow
rout
enter
mammalian
cell
gene
express
inhibit
lysosomotrop
agent
eg
chloroquin
block
endosom
matur
initi
suggest
transduct
liver
specif
asialoglycoprotein
could
involv
viru
bind
howev
van
loo
et
al
show
cell
express
asialoglycoprotein
receptor
could
success
transduc
thu
asialoglycoprotein
key
determin
also
shown
electrostat
interact
heparan
sulfat
moieti
might
necessari
baculoviru
bind
mammalian
cell
surfac
howev
followup
report
confirm
find
natur
receptor
remain
unclear
contrast
viral
envelop
glycoprotein
shown
essenti
viru
attach
endosom
escap
support
find
baculoviru
overexpress
addit
endogen
copi
incorpor
approxim
normal
amount
virion
surfac
exhibit
report
gene
express
varieti
mammalian
cell
compar
similar
virus
normal
amount
studi
phospholipid
cell
surfac
suggest
serv
import
dock
point
thu
facilit
viral
entri
mammalian
cell
transient
deplet
calcium
use
egta
pretreat
bilello
et
al
demonstr
paracellular
junction
complex
import
baculovir
entri
primari
hepatocyt
gener
assum
escap
endosom
set
block
transduct
mammalian
cell
baculoviru
howev
recent
studi
show
transduct
block
lie
endosom
escap
rather
cytoplasm
traffick
nuclear
import
viru
capsid
cytoplasm
nucleocapsid
appear
induc
format
actin
filament
probabl
facilit
transport
viral
nucleocapsid
nucleu
cytochalasin
strongli
reduc
transduct
effici
deliveri
nucleocapsid
cytoplasm
contrast
recent
found
incub
cell
pb
transduct
result
significantli
higher
viru
entri
higher
transduct
effici
compar
incub
dmem
suggest
viru
intern
may
bottleneck
well
overal
event
respons
viru
uptak
detail
mechan
intracellular
movement
nuclear
entri
viru
still
larg
unknown
baculoviru
display
tropism
transduct
effici
baculoviru
manipul
modifi
envelop
protein
modif
perform
fuse
heterolog
protein
peptid
infram
nterminu
gene
control
polyhedrin
promot
fusion
protein
express
addit
copi
transloc
plasma
membran
incorpor
viral
envelop
viru
bud
proof
principl
first
approach
fuse
envelop
protein
modifi
viru
bind
receptor
cell
similar
strategi
appli
construct
avidindisplay
baculoviru
show
increas
transduct
effici
rat
malign
glioma
cell
increas
rabbit
aortic
smooth
muscl
cell
compar
wildtyp
baculoviru
baculoviru
display
heterolog
envelop
protein
vesicular
stomat
viru
g
protein
vsvg
also
construct
transduc
human
hepatoma
rat
neuron
cell
effici
roughli
greater
baculoviru
lack
vsvg
pseudotyp
viru
also
transduc
cell
line
transduc
low
level
unmodifi
baculoviru
thu
broaden
tropism
enhanc
transduct
effici
wider
tropism
attribut
increas
transport
baculoviru
dna
nuclei
rather
increas
cell
bind
viru
uptak
contrast
specif
target
baculoviru
mammalian
cell
display
singlechain
antibodi
fragment
specif
carcinoembryon
antigen
cea
synthet
igg
bind
domain
also
demonstr
addit
baculoviru
display
technolog
util
construct
screen
eukaryot
epitop
librari
context
epitop
eldkwa
specif
neutral
mab
insert
antigen
site
influenza
viru
hemagglutinin
flank
addit
random
amino
acid
pool
hemagglutinin
gene
clone
baculoviru
individu
clone
display
epitop
markedli
increas
bind
capac
pool
variant
screen
rapidli
fluoresc
activ
cell
sort
note
howev
express
control
late
promot
may
lead
heterogen
viru
popul
possess
variou
amount
fusion
protein
henc
vari
properti
might
resolv
insert
fusion
gene
genom
locu
copi
contain
fusion
partner
ii
express
fusion
protein
earli
promot
recent
baculoviru
capsid
display
also
develop
fusion
made
cterminu
major
capsid
protein
rather
without
compromis
viral
titer
function
demonstr
incorpor
green
fluoresc
protein
gfp
viru
capsid
interfer
capsid
assembl
allow
visual
viru
biodistribut
vivo
capsidmodifi
baculoviru
hold
great
promis
nuclear
subcellular
target
transgen
thank
larg
dna
genom
recombin
baculoviru
offer
attract
mean
product
viral
vector
gene
deliverygen
therapi
purpos
product
mani
viral
vector
requir
either
plasmid
transfect
produc
cell
line
helper
viru
infect
instanc
gene
essenti
replic
packag
adenovir
vector
kb
deliv
express
singl
baculoviru
cotransfect
plasmid
vector
harbor
invert
termin
repeat
itr
pack
signal
wildtyp
viru
well
report
gene
codeliveri
result
gener
fulli
delet
adenoviru
vector
free
helper
viru
techniqu
also
exploit
product
adenoassoci
viru
aav
whose
use
hamper
lack
simpl
effici
vector
product
method
mammalian
produc
cell
cotransduc
virus
baculoviru
harbor
report
gene
flank
aav
itr
baculoviru
express
aav
rep
gene
helper
adenoviru
express
aav
cap
gene
simultan
deliveri
produc
infecti
recombin
aav
particl
constitut
option
improv
largescal
recombin
aav
vector
product
besid
viru
prepar
ramo
et
al
recent
investig
feasibl
use
baculovirusmammalian
cell
system
protein
product
investig
two
protocol
optim
cell
cultur
viru
transduct
achiev
volumetr
yield
secret
protein
asp
mgl
laboratori
applic
baculoviru
expand
product
hepat
delta
viru
hdv
vlp
hdv
replic
cultur
cell
line
thu
difficult
propag
therefor
studi
hdv
particl
assembl
mainli
reli
cdna
transfect
suffer
howev
low
effici
hinder
subsequ
structur
immunolog
studi
hdv
vlp
demonstr
cotransduct
hepatoma
cell
line
recombin
baculovirus
one
express
hepat
larg
delta
antigen
anoth
express
hepat
b
surfac
antigen
hbsag
lead
selfassembl
secret
hdv
vlp
yield
ng
hbsag
per
ml
secret
particl
approxim
achiev
plasmid
transfect
vlp
synthesi
also
demonstr
bhk
cell
process
transfer
novel
oscil
bioreactor
product
larger
scale
one
bioreactor
run
ml
work
volum
yield
hbsag
substanti
increas
total
particl
yield
thu
enabl
futur
structur
immunolog
studi
vlp
comparison
stabl
cell
line
gene
express
level
vlp
composit
easili
manipul
simpli
vari
viru
concentr
addit
express
protein
obtain
day
therefor
baculovirusmammalian
cell
express
system
may
serv
transient
express
system
earli
evalu
protein
interest
stabl
cell
line
gener
evalu
approach
success
appli
assay
develop
human
osteosarcoma
ho
cell
similarli
cell
cell
fusion
assay
mimic
hiv
viralcel
fusion
process
develop
base
baculoviru
system
assay
ho
cell
stabli
express
ltrluciferas
serv
recipi
host
cell
cell
line
transduc
baculoviru
express
viral
protein
tat
rev
repres
viru
interact
result
fusion
cell
transfer
tat
cytoplasm
ho
cell
tat
turn
bind
ltr
region
luciferas
report
activ
transcript
lead
increas
cellular
luciferas
activ
assay
demonstr
robust
reproduc
highthroughput
surrog
assay
evalu
effect
compound
viral
fusion
host
cell
system
could
also
facilit
assess
differ
promot
strength
well
tempor
spatial
regul
across
mammalian
cell
differ
origin
similar
hdv
hepat
b
viru
hbv
hcv
capabl
replic
cultur
cell
thu
evalu
novel
antivir
strategi
hinder
lack
conveni
reliabl
vitro
cultur
system
overcom
problem
recombin
baculovirus
construct
carri
deliv
genom
hbv
hcv
hepatoma
cell
line
approach
replic
hbv
dna
rna
express
viral
gene
detect
viral
replic
evidenc
presenc
high
level
intracellular
replic
intermedi
protect
hbv
dna
medium
success
hbv
replic
thu
allow
establish
highli
flexibl
system
studi
effect
hbv
replic
accumul
coval
close
circular
dna
ii
crossresist
profil
hbv
mutant
antihepadnavir
compound
hcv
fulllength
minigenom
tetracyclineinduc
promot
also
deliv
cell
regul
transcript
viral
polypeptid
process
demonstr
thu
provid
novel
tool
analysi
hcv
replic
hostcel
interact
gener
stabl
cell
line
normal
baculovirusmedi
gene
express
last
approxim
week
result
cell
divis
gradual
extinct
transgen
express
also
attribut
degrad
baculovir
dna
degrad
reveal
hepatoma
cell
articular
chondrocyt
howev
found
transduct
cho
cell
baculoviru
express
neomycin
phosphotransferas
result
isol
cho
cell
stabli
express
gfp
select
use
antibiot
frequenc
resist
coloni
format
approxim
transduc
cell
group
confirm
discret
portion
baculoviru
dna
randomli
integr
singlecopi
fragment
rang
size
kb
kb
period
assay
stabl
clone
show
loss
transgen
express
month
period
coupl
high
transduct
effici
high
frequenc
emerg
stabl
transduct
make
baculoviru
valuabl
tool
deriv
human
cell
line
either
difficult
isol
larg
number
difficult
transfect
method
vivo
gene
therapi
thank
highli
effici
gene
deliveri
baculoviru
captur
increas
interest
vector
vitro
vivo
gene
deliveri
howev
report
success
vivo
applic
limit
complement
system
appear
potent
barrier
vivo
gene
therapi
effici
gene
transfer
hepatocyt
complementdefici
mice
greatli
enhanc
inactiv
baculoviru
human
plasma
whole
blood
prevent
treatment
cobra
venom
factor
altern
approach
adopt
avoid
contact
baculoviru
vector
blood
compon
use
silast
collar
transduct
adventiti
cell
rabbit
carotid
arteri
achiev
effici
compar
obtain
adenovir
vector
gene
express
transient
arteri
structur
endothelium
remain
intact
baculoviru
transduct
although
sign
inflamm
detect
unmodifi
baculoviru
vector
also
inject
rodent
brain
complement
protein
may
reach
presenc
intact
bloodbrain
barrier
andor
complement
level
brain
insuffici
affect
gene
transfer
vivo
inject
brain
baculoviru
specif
transduc
epithelium
choroid
plexu
ventricl
transduct
effici
high
thu
baculoviru
seem
especi
use
target
choroid
plexu
cell
cuttingedg
approach
allevi
complement
inactiv
problem
gener
complementresist
baculoviru
display
decayacceler
factor
regul
block
complement
central
step
classic
altern
pathway
complementresist
baculoviru
vector
express
addit
human
coagul
factor
ix
hfix
allow
substanti
improv
gene
transfer
complementsuffici
neonat
rat
vivo
local
inject
liver
parenchyma
gene
express
transient
probabl
result
gener
antibodi
direct
transgen
product
hfix
might
lead
clearanc
either
express
hfix
protein
andor
posit
transduc
cell
altern
baculoviru
pseudotyp
display
vsvg
envelop
vsvgmodifi
viru
enhanc
gene
transfer
effici
mous
skelet
muscl
vivo
transgen
express
last
mice
balbc
mice
vsvgmodifi
baculoviru
also
exhibit
greater
resist
inactiv
anim
sera
transduc
cerebr
cortex
testi
mice
direct
inocul
vivo
anoth
potenti
barrier
may
presenc
heparin
heparinlik
factor
block
baculovirusmedi
gene
deliveri
cell
cultur
intercellular
junction
may
addit
hurdl
transient
disrupt
junction
edta
treatment
prior
transduct
improv
gene
deliveri
effici
longterm
cultur
primari
hepatocyt
lead
perman
altern
hepatocyt
ultrastructur
albumin
mrna
protein
express
profil
studi
also
suggest
import
basolater
surfac
viru
entri
least
cell
type
laboratori
howev
transient
disrupt
cell
junction
fail
effect
enhanc
baculovirusmedi
gene
transfer
chondrocyt
cell
cultur
overconflu
impli
factor
addit
paracellular
junction
complex
might
involv
transduct
cell
anoth
problem
associ
baculoviru
gene
deliveri
vector
purif
ultracentrifug
often
lead
viru
aggreg
addit
ultracentrifug
process
timeconsum
labor
intens
difficult
scale
resolv
problem
construct
recombin
baculoviru
hexahistidin
tag
display
viral
envelop
enabl
viru
purif
simpl
immobil
metal
affin
chromatographi
high
puriti
methodolog
obviat
need
success
ultracentrifug
step
may
employ
purifi
viral
vector
gene
therapi
studi
ex
vivo
gene
therapi
date
gene
therapi
studi
use
baculoviru
vector
focus
vivo
experi
yet
rel
littl
known
potenti
baculoviru
ex
vivo
therapi
one
relev
report
publish
sandig
et
al
establish
ex
vivo
perfus
model
human
liver
segment
recombin
baculoviru
perfus
liver
segment
min
reason
transduct
rate
achiev
perfus
part
liver
tissu
studi
verifi
first
time
baculovirusmedi
gene
transfer
possibl
liver
tissu
encourag
futur
studi
includ
situ
perfus
intact
liver
baculoviru
vector
anim
model
recent
also
demonstr
highli
effici
baculovirusmedi
gene
transfer
articular
chondrocyt
human
msc
candid
cell
sourc
cartilag
tissu
engin
importantli
normal
differenti
state
chondrocyt
msc
retain
baculoviru
transduct
experi
regard
msc
suggest
phenotyp
chang
along
adipogen
differenti
pathway
posit
influenc
baculoviru
transduct
may
implic
two
possibl
applic
msc
may
transduc
baculoviru
express
specif
factor
eg
bfgf
promot
expans
regul
differenti
via
autocrin
paracrin
effect
factor
supplement
factor
medium
may
omit
ii
differenti
msc
toward
specif
lineag
pathway
may
induc
first
commit
progenitor
cell
transduc
ex
vivo
recombin
baculoviru
express
appropri
growth
factor
eg
seed
onto
polymer
scaffold
implant
anim
model
tissu
regener
although
sustain
transgen
express
restrict
degrad
baculovir
dna
within
cell
nonrepl
degrad
characterist
prove
baculoviru
may
safe
gene
deliveri
vehicl
tissu
engin
longterm
express
critic
immunolog
respons
potenti
vaccin
vector
host
respons
baculoviru
uptak
either
vitro
vivo
evalu
gronowski
et
al
report
administr
baculoviru
vitro
induc
interferon
ifn
product
human
murin
cell
line
induc
vivo
protect
mice
encephalomyocard
viru
infect
recent
studi
discov
presenc
baculoviru
disrupt
phenobarbit
gene
induct
potent
transcript
activ
event
characterist
highli
differenti
hepatocyt
repress
express
albumin
gene
neither
camp
pka
activ
affect
viru
baculoviru
transduct
also
induc
express
cytokin
primari
hepatocyt
find
rais
concern
whether
properti
compromis
use
baculoviru
vector
vivo
gene
therapi
human
investig
need
ensur
safeti
baculoviru
vector
despit
abil
baculoviru
induc
immun
respons
exploit
abe
et
al
found
intranas
inocul
wildtyp
baculoviru
elicit
strong
innat
immun
respons
protect
mice
lethal
challeng
influenza
viru
feasibl
use
baculoviru
vaccin
carrier
also
demonstr
aoki
et
al
found
recombin
baculoviru
express
glycoprotein
gb
pseudorabi
viru
induc
antibodi
gb
protein
mice
thu
suggest
recombin
baculoviru
could
serv
vaccin
candid
pseudorabi
similarli
vivo
administr
baculoviru
express
hfix
elicit
antibodi
hfix
antibodi
titer
proport
amount
protein
produc
viru
recent
facciaben
et
al
demonstr
intramuscular
inject
baculoviru
express
cea
induc
measur
anticeaspecif
tcell
respons
immunogen
properti
baculoviru
restrict
cea
intramuscular
inject
anoth
baculoviru
express
glycoprotein
hcv
induc
tcell
respons
interestingli
pseudotyp
display
vsvg
envelop
minim
dose
requir
elicit
measur
tcell
respons
less
indic
vsvgpseudotyp
appear
potent
immunogen
unmodifi
viru
find
agre
previou
statement
baculoviru
display
vsvg
confer
effici
immunogen
express
transduc
cell
also
like
baculoviru
mediat
immun
respons
antigen
display
viral
surfac
regard
immunodomin
antigen
site
footandmouth
diseas
viru
fmdv
display
baculoviru
envelop
abl
bind
panel
fmdvspecif
mab
indic
preserv
antigen
epitop
viru
envelop
recent
studi
show
immun
adjuvantfre
baculoviru
display
rodent
malaria
plasmodium
berghei
circumsporozoit
protein
pbcsp
envelop
induc
high
level
antibodi
cell
pbcsp
protect
mice
sporozoit
challeng
studi
substanti
potenti
baculoviru
display
immunogen
vaccin
candid
valu
baculoviru
recombin
protein
express
insect
cell
long
proven
extrem
high
yield
baculovirusinfect
insect
cell
larva
make
attract
tool
pharmaceut
protein
product
despit
inabl
process
protein
correctli
rapid
advanc
cell
engin
may
overcom
drawback
render
baculoviru
proper
system
largescal
protein
product
best
knowledg
insect
cellderiv
recombin
protein
gain
offici
approv
us
food
drug
administr
nonetheless
protein
produc
insect
cell
preclin
stage
particularli
promis
field
viral
vaccin
format
virusmimick
multim
essenti
elicit
protect
immun
respons
hcv
vaccin
might
first
human
therapeut
express
insect
cell
broad
rang
suscept
mammalian
cell
coupl
nontox
nonrepl
natur
make
baculoviru
use
tool
studi
express
function
gene
product
gene
therapi
vector
baculoviru
possess
follow
extra
advantag
acmnpv
genom
larg
thu
render
viru
flexibl
carri
multipl
gene
larg
insert
ii
recombin
baculovirus
easi
construct
produc
high
titer
simpli
infect
insect
cell
iii
purif
baculoviru
readili
perform
ultracentrifug
altern
newli
develop
affin
chromatograph
techniqu
last
two
featur
greatli
simplifi
largescal
prepar
high
titer
baculovir
vector
addit
therapeut
gene
baculoviru
may
serv
promis
vector
deliveri
cdna
infecti
rna
virus
toward
antisens
therapi
approach
concept
may
appli
deliveri
sirna
silenc
specif
target
gene
combin
ex
vivo
gene
transfer
tissu
engin
hold
great
promis
well
one
bottleneck
applic
baculoviru
lie
short
durat
transgen
express
may
overcom
select
proper
promot
silenc
develop
proper
superinfect
protocol
effect
deliv
fresh
gene
cell
baculoviru
may
also
appli
conjunct
viral
vector
escap
either
preexist
therapyinduc
antivir
immun
summari
baculoviru
use
effici
vector
gene
deliveri
insect
mammalian
cell
wide
varieti
applic
